Hands On Diagnostics Study Finds A Groundbreaking Approach To Treating Neuropathy With The Neufit NEUBIE Device

(MENAFN- PR Newswire) "Neuropathy is incredibly common among the aging population, regardless of disease states. There is currently no known cure for neuropathy, and most treatments address acute symptoms with no lasting impact," says Dr. Ramona von Leden, VP of Research and Clinical Affairs for NeuFit. "NeuFit's specialized approach to rehab focuses on supporting the function of the nervous system, and we are seeing remarkable results on patients with neuropathy."

Unlike conventional methods that primarily focus on structural rehabilitation, the NEUBIE targets the nervous system, the body's control center for responses to injury or dysfunction. The use of DC over traditional alternating current (AC) in the NEUBIE device sets NeuFit apart from other electrical stimulation therapies. This promotes healing, reduces pain, and improves sensorimotor function more rapidly than AC, which can hinder effective therapy and reinforce inefficient movement patterns.

Neuropathy, characterized by nerve damage that results in pain, weakness, and numbness, presents significant treatment challenges. NeuFit and HODS are making groundbreaking strides in this area by combining advanced diagnostics with innovative therapy. HODS specializes in electromyography (EMG) and nerve conduction studies, providing detailed insights into nerve function. By integrating these diagnostic tools with NeuFit's therapeutic approach, patients receive comprehensive evaluations and tailored treatment plans that can be adjusted in real-time for optimal results.

"The findings from this study show that we can make tangible improvements to nerve function and related subjective measures in patients suffering from neuropathy," continues Dr. von Leden. "NeuFit's innovative approach, combined with HODS' diagnostic expertise, is redefining neurological rehabilitation. By focusing on the nervous system and leveraging advanced technology, NeuFit offers a promising future for patients with challenging conditions like neuropathy."

Link to article:

Citation: Kostopoulos, Dimitrios, Rizopoulos, Konstantine, McGilvrey, Joe, Hauskey, Jennifer, Courcier, Jeff, Connor-Israel, Kay, Koster, Harry, von Leden, Ramona, An Open-Label Comparative Study of the Impact of Two Types of Electrical Stimulation (Direct Current Neuromuscular Electrical Stimulation and Transcutaneous Electrical Stimulation) on Physical Therapy Treatment of Diabetic Peripheral Neuropathy, Journal of Diabetes Research, 2025, 9970124, 10 pages, 2025.

Media Contact:
Dr. Ramona von Leden, PhD
Vice President of Research and Clinical Affairs
[email protected]

SOURCE NeuFit

MENAFN05022025003732001241ID1109172614